Committed to innovative surgical solutions

Thank you for visiting us

About Us

We are developing next-generation, advanced surgical solutions

Innoblative, a private medical device company addressing clinical unmet needs for patients with breast cancer and other soft tissue disease, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the company's SIRA® RFA Electrosurgical Device.

To learn more, click on one of the following items